Inside Health Policy wrote about Rep. Greg Murphy’s (R-NC) new bill, which CAHC supports. The Every Dollar Counts Act would significantly enhance the cost-saving potential of TrumpRx by requiring that the cash prices patients pay for drugs on direct-to-consumer platforms be counted toward deductibles and out-of-pocket maximums in private plans. While the bill wouldn’t codify TrumpRx as called for by the White House, it would significantly bolster its value via the significant cost-sharing tweak reportedly sought by the administration.
The Council for Affordable Health Coverage (CAHC) commended the bill’s announcement and said the measure would help deliver real savings to patients through drug discounts as high as 95% off a drug’s list price.
“This is not a new entitlement. It is not a government price control. It is a common-sense market reform that aligns incentives around affordability, transparency, and consumer choice,” CAHC said in a statement upon the bill’s introduction. “No patient should be punished for making a smart, cost-conscious choice.”